0001437749-23-023001.txt : 20230810 0001437749-23-023001.hdr.sgml : 20230810 20230810153326 ACCESSION NUMBER: 0001437749-23-023001 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WRAP TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001702924 STANDARD INDUSTRIAL CLASSIFICATION: ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480] IRS NUMBER: 980551945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38750 FILM NUMBER: 231158984 BUSINESS ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 800-583-2652 MAIL ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 10-Q 1 wrap20230630_10q.htm FORM 10-Q wrap20230630_10q.htm
0001702924 false --12-31 2023 Q2 1 3 1 3 3 2 0 1 0 0 0 0 00017029242023-01-012023-06-30 thunderdome:item xbrli:shares 0001702924wrap:IntrensicLLCMemberus-gaap:SubsequentEventMember2023-08-092023-08-09 iso4217:USD xbrli:pure 0001702924wrap:IntrensicLLCMemberus-gaap:SubsequentEventMember2023-08-09 0001702924us-gaap:SubsequentEventMemberwrap:RegisteredDirectOfferingMember2023-07-052023-07-05 0001702924us-gaap:SubsequentEventMemberwrap:RegisteredDirectOfferingMember2023-07-012023-07-05 0001702924wrap:RegisteredDirectOfferingMember2023-01-012023-06-30 iso4217:USDxbrli:shares 0001702924us-gaap:SeriesAPreferredStockMemberus-gaap:SubsequentEventMemberwrap:RegisteredDirectOfferingMember2023-07-05 0001702924wrap:WarrantsIssuedInRegisteredDirectOfferingMemberus-gaap:SubsequentEventMember2023-07-05 0001702924us-gaap:SeriesAPreferredStockMemberus-gaap:SubsequentEventMemberwrap:RegisteredDirectOfferingMember2023-07-052023-07-05 0001702924us-gaap:SeriesAPreferredStockMemberus-gaap:SubsequentEventMemberwrap:RegisteredDirectOfferingMember2023-06-292023-07-05 00017029242022-01-012022-06-30 00017029242022-04-012022-06-30 00017029242023-04-012023-06-30 0001702924srt:AsiaPacificMember2022-01-012022-06-30 0001702924srt:AsiaPacificMember2023-01-012023-06-30 0001702924srt:AsiaPacificMember2022-04-012022-06-30 0001702924srt:AsiaPacificMember2023-04-012023-06-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-01-012022-06-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2023-01-012023-06-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-04-012022-06-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2023-04-012023-06-30 0001702924srt:AmericasMember2022-01-012022-06-30 0001702924srt:AmericasMember2023-01-012023-06-30 0001702924srt:AmericasMember2022-04-012022-06-30 0001702924srt:AmericasMember2023-04-012023-06-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2023-01-012023-06-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2023-01-012023-06-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-01-012023-06-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-01-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2023-01-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2023-01-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-01-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-01-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorFourMember2022-04-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorThreeMember2022-04-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2022-04-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-04-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-04-012022-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2023-04-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-04-012023-06-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-04-012023-06-30 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2022-01-012022-06-30 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2023-01-012023-06-30 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2023-04-012023-06-30 0001702924wrap:MrElwoodNorrisMember2023-01-012023-06-30 00017029242023-06-30 0001702924wrap:ProfessionalServicesAndTechnologyAcquisitionAgreementMember2022-11-222022-11-22 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-06-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-01-012022-06-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-04-012022-06-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-01-012023-06-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-04-012023-06-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2016-09-30 00017029242022-01-012022-12-31 utr:Y 0001702924us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-30 0001702924us-gaap:RestrictedStockUnitsRSUMember2023-06-30 0001702924us-gaap:EmployeeStockOptionMember2023-01-012023-06-30 0001702924us-gaap:EmployeeStockOptionMember2023-06-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-06-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-06-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-04-012022-06-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-01-012022-06-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-04-012022-04-01 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2023-01-012023-06-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2023-04-012023-06-30 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-31 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-12-31 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-01-012022-06-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-04-012022-06-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2023-01-012023-06-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2023-04-012023-06-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MaximumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MinimumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-30 0001702924us-gaap:EmployeeStockOptionMember2022-01-012022-06-30 0001702924us-gaap:PerformanceSharesMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMember2023-06-30 0001702924wrap:ServicebasedOptionsMemberwrap:The2017StockIncentivePlanMember2023-06-30 00017029242022-12-31 0001702924wrap:The2017StockIncentivePlanMember2022-01-012022-01-31 0001702924wrap:The2017StockIncentivePlanMember2022-04-012022-04-30 0001702924wrap:The2017StockIncentivePlanMember2023-06-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-012022-06-30 0001702924wrap:The2017StockIncentivePlanMember2021-06-012021-06-30 0001702924wrap:The2017StockIncentivePlanMember2019-05-012019-05-31 0001702924wrap:The2017StockIncentivePlanMember2017-03-31 00017029242022-06-30 00017029242021-12-31 0001702924wrap:CommissionsPayableMember2022-12-31 0001702924wrap:FormerCeoPayableMember2023-06-30 0001702924wrap:RegisteredDirectOfferingMember2023-06-30 0001702924wrap:RegisteredDirectOfferingMember2023-06-292023-06-29 0001702924wrap:SyzygyLicensingLLCMember2022-12-31 0001702924wrap:SyzygyLicensingLLCMember2023-06-30 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-31 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2023-06-30 0001702924us-gaap:TrademarksMember2022-12-31 0001702924us-gaap:TrademarksMember2023-06-30 0001702924us-gaap:PatentsMember2022-12-31 0001702924us-gaap:PatentsMember2023-06-30 0001702924us-gaap:FurnitureAndFixturesMember2022-12-31 0001702924us-gaap:FurnitureAndFixturesMember2023-06-30 0001702924us-gaap:ComputerEquipmentMember2022-12-31 0001702924us-gaap:ComputerEquipmentMember2023-06-30 0001702924wrap:ToolingMember2022-12-31 0001702924wrap:ToolingMember2023-06-30 0001702924wrap:ProductionAndLabEquipmentMember2022-12-31 0001702924wrap:ProductionAndLabEquipmentMember2023-06-30 0001702924us-gaap:FairValueInputsLevel1Member2022-12-31 0001702924us-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2022-12-31 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-31 0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924us-gaap:FairValueInputsLevel1Member2023-06-30 0001702924us-gaap:FairValueInputsLevel1Member2023-01-012023-06-30 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2023-06-30 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-06-30 0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2023-06-30 0001702924wrap:USTreasurySecuritiesConsideredCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-06-30 0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-06-30 0001702924us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-06-30 0001702924wrap:ExtendedProductWarrantiesMember2022-12-31 0001702924wrap:TrainingMember2022-12-31 0001702924wrap:VirtualRealityTrainingMember2022-12-31 0001702924wrap:ExtendedProductWarrantiesMember2023-06-30 0001702924wrap:TrainingMember2023-06-30 0001702924wrap:VirtualRealityTrainingMember2023-06-30 0001702924wrap:DeferredRevenueMember2023-06-30 0001702924wrap:CustomerDepositsMember2023-06-30 0001702924wrap:DeferredRevenueMember2023-01-012023-06-30 0001702924wrap:CustomerDepositsMember2023-01-012023-06-30 0001702924wrap:DeferredRevenueMember2022-12-31 0001702924wrap:CustomerDepositsMember2022-12-31 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2022-01-012022-06-30 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2023-01-012023-06-30 0001702924wrap:PatentsAndTrademarksMember2022-01-012022-06-30 0001702924wrap:PatentsAndTrademarksMember2023-01-012023-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-30 0001702924us-gaap:RetainedEarningsMember2022-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-06-30 0001702924us-gaap:CommonStockMember2022-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-30 0001702924us-gaap:RetainedEarningsMember2022-01-012022-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-30 0001702924us-gaap:CommonStockMember2022-01-012022-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31 0001702924us-gaap:RetainedEarningsMember2021-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001702924us-gaap:CommonStockMember2021-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-30 0001702924us-gaap:RetainedEarningsMember2022-04-012022-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-30 0001702924us-gaap:CommonStockMember2022-04-012022-06-30 00017029242022-03-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-31 0001702924us-gaap:RetainedEarningsMember2022-03-31 0001702924us-gaap:AdditionalPaidInCapitalMember2022-03-31 0001702924us-gaap:CommonStockMember2022-03-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0001702924us-gaap:RetainedEarningsMember2023-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-06-30 0001702924us-gaap:CommonStockMember2023-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-30 0001702924us-gaap:RetainedEarningsMember2023-01-012023-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-30 0001702924us-gaap:CommonStockMember2023-01-012023-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0001702924us-gaap:RetainedEarningsMember2022-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001702924us-gaap:CommonStockMember2022-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-30 0001702924us-gaap:RetainedEarningsMember2023-04-012023-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-30 0001702924us-gaap:CommonStockMember2023-04-012023-06-30 00017029242023-03-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-31 0001702924us-gaap:RetainedEarningsMember2023-03-31 0001702924us-gaap:AdditionalPaidInCapitalMember2023-03-31 0001702924us-gaap:CommonStockMember2023-03-31 00017029242023-08-09
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 000-55838

 

wrap20230630_10qimg001.jpg

 

Wrap Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

98-0551945

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

1817 W 4th Street

Tempe, Arizona 85281

(Address of principal executive offices) (Zip Code)

 

(800) 583-2652

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

WRAP

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒

 

As of August 9, 2023 a total of 41,968,389 shares of the Registrant’s common stock, par value $0.0001, (“Common Stock”) were issued and outstanding.

 

 

 

WRAP TECHNOLOGIES, INC.

 

INDEX

 

PART I. FINANCIAL INFORMATION

Page

   

Item 1.

Financial Statements:

 
 

Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022

1
 

Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2023 and 2022 (unaudited)

2
 

Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2023 and 2022 (unaudited)

3
 

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited)

5
 

Notes to Unaudited Condensed Consolidated Interim Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

27

Item 4.

Controls and Procedures

27
     

PART II. OTHER INFORMATION

 
     

Item 1.

Legal Proceedings

27

Item 1A.

Risk Factors

28

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3.

Defaults Upon Senior Securities

28

Item 4.

Mine Safety Disclosures

28

Item 5.

Other Information

28

Item 6.

Exhibits

28
     

SIGNATURES

29

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Wrap Technologies, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share amounts)

 

   

June 30,

2023

   

December 31,

2022

 

ASSETS

               
Current assets:                

Cash and cash equivalents

  $ 11,688     $ 5,330  

Short-term investments

    6,500       13,949  

Accounts receivable and contract assets, net

    1,949       2,830  

Inventories, net

    6,520       3,975  

Prepaid expense and other current assets

    722       775  

Total current assets

    27,379       26,859  

Property and equipment, net

    588       758  

Operating lease right-of-use asset, net

    232       285  

Intangible assets, net

    2,588       2,569  

Other assets

    69       100  

Total assets

  $ 30,856     $ 30,571  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               
Current liabilities:                

Accounts payable

  $ 1,928     $ 1,419  

Accrued liabilities

    8,562       1,463  

Customer deposits

    3       -  

Deferred revenue- short term

    211       166  

Operating lease liability - short term

    113       108  

Total current liabilities

    10,817       3,156  
                 
Long-term liabilities:                

Deferred revenue- long term

    129       167  

Operating lease liability - long term

    135       193  

Total long-term liabilities

    264       360  

Total liabilities

    11,081       3,516  
                 

Commitments and contingencies (Note 11)

               
                 
Stockholders' equity:                

Preferred stock - 5,000,000 authorized; par value $0.0001 per share; none issued and outstanding

    -       -  

Common stock - 150,000,000 authorized; par value $0.0001 per share; 41,910,687 and 41,175,993 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively

    4       4  

Additional paid-in capital

    96,182       94,333  

Accumulated deficit

    (76,411 )     (67,376 )

Accumulated other comprehensive loss

    -       94  

Total stockholders' equity

    19,775       27,055  

Total liabilities and stockholders' equity

  $ 30,856     $ 30,571  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

(unaudited)

 

   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2023

   

2022

   

2023

   

2022

 

Revenue:

                               

Product sales

  $ 1,034     $ 969     $ 1,650     $ 2,431  

Other revenue

    168       196       263       333  

Total revenue

    1,202       1,165       1,913       2,764  

Cost of revenue

    534       708       893       1,640  

Gross profit (loss)

    668       457       1,020       1,124  
                                 

Operating expense:

                               

Selling, general and administrative

    4,745       3,764       8,286       8,370  

Research and development

    1,002       1,476       2,073       2,971  

Total operating expense

    5,747       5,240       10,359       11,341  

Loss from operations

    (5,079 )     (4,783

)

    (9,339 )     (10,217

)

                                 

Other income (expense):

                               

Interest income

    88       -       324       2  

Other

    (16 )     (2

)

    (20 )     (2

)

Total other income (expense)

    72       (2

)

    304       -  

Net loss

  $ (5,007 )   $ (4,785

)

  $ (9,035 )   $ (10,217

)

                                 

Net loss per basic and diluted common share

  $ (0.12 )   $ (0.12

)

  $ (0.22 )   $ (0.25

)

Weighted average common shares used to compute net loss per basic and diluted common share

    41,709,718       40,978,820       41,483,669       40,943,241  
                                 
Comprehensive loss:                                

Net loss

  $ (5,007 )   $ (4,785 )   $ (9,035 )   $ (10,217

)

Net unrealized gain (loss) on short-term investments

    -       12       -       (11

)

Comprehensive loss

  $ (5,007 )   $ (4,773 )   $ (9,035 )   $ (10,228

)

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Stockholders' Equity

(in thousands, except share amounts)

(unaudited)

 

Three Months Ended June 30, 2023

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
    Common Stock    

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at April 1, 2023

    41,270,300     $ 4     $ 94,961     $ (71,404

)

  $ -     $ 23,561  

Common shares issued upon exercise of stock options

    -       -       -       -       -       -  

Share-based compensation expense

    -       -       1,221       -       -       1,221  

Common shares issued upon vesting of restricted stock units

    640,387       -       -       -       -       -  

Net loss for the period

    -       -       -       (5,007 )     -       (5,007

)

Balance at June 30, 2023

    41,910,687     $ 4     $ 96,182     $ (76,411 )   $ -     $ 19,775  

 

Six Months Ended June 30, 2023

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
    Common Stock    

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2023

    41,175,993     $ 4     $ 94,333     $ (67,376

)

  $ 94     $ 27,055  

Common shares issued upon exercise of stock options

    250       -       -       -       -       -  

Share-based compensation expense

    -       -       1,849       -       -       1,849  

Common shares issued upon vesting of restricted stock units

    734,444       -       -       -       -       -  

Settlement – US Treasury bills

    -       -       -       -       (94 )     (94 )

Net loss for the period

    -       -       -       (9,035 )     -       (9,035

)

Balance at June 30, 2023

    41,910,687     $ 4     $ 96,182     $ (76,411 )   $ -     $ 19,775  

 

 

Three Months Ended June 30, 2022

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at April 1, 2022

    40,951,197     $ 4     $ 92,129     $ (55,191

)

  $ (29

)

  $ 36,913  

Share-based compensation expense

    -       -       727       -       -       727  

Common shares issued upon vesting of restricted stock units

    40,964       -       -       -       -       -  

Net unrealized gain on short-term investments

    -       -       -       -       12       12  

Net loss for the period

    -       -       -       (4,785

)

    -       (4,785

)

Balance at June 30, 2022

    40,992,161     $ 4     $ 92,856     $ (59,976

)

  $ (17

)

  $ 32,867  

 

Six Months Ended June 30, 2022

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2022

    40,851,945     $ 4     $ 91,025     $ (49,759

)

  $ (6

)

  $ 41,264  

Common shares issued upon exercise of stock options

    50,000       -       75       -       -       75  

Share-based compensation expense

    -       -       1,756       -       -       1,756  

Common shares issued upon vesting of restricted stock units

    90,216       -       -       -       -       -  

Common shares issued for services

    -       -       -       -       -       -  

Net unrealized loss on short-term investments

    -       -       -       -       (11

)

    (11

)

Net loss for the period

    -       -       -       (10,217

)

    -       (10,217

)

Balance at June 30, 2022

    40,992,161     $ 4     $ 92,856     $ (59,976

)

  $ (17

)

  $ 32,867  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

 

Wrap Technologies, Inc.

 

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

   

Six Months Ended June 30,

 
   

2023

   

2022

 

Cash Flows From Operating Activities:

               

Net loss

  $ (9,035 )   $ (10,217 )
Adjustments to reconcile net loss to net cash used in operating activities:                

Depreciation and amortization

    403       380  

Share-based compensation

    1,849       1,756  

Warranty provision

    (44 )     45  

Non-cash lease expense

    53       49  

Provision for doubtful accounts

    (4 )     8  

Changes in assets and liabilities:

               

Accounts receivable

    884       2,446  

Inventories

    (2,545 )     (467

)

Prepaid expense and other current assets

    53       168  

Accounts payable

    508       (417

)

Operating lease liability

    (52 )     (41

)

Customer deposits

    3       (39 )

Accrued liabilities and other

    7,149       106  

Warranty settlement

    (6 )     (63 )

Deferred revenue

    8       79  

Net cash used in operating activities

    (776 )     (6,207

)

                 

Cash Flows From Investing Activities:

               

Purchase of short-term investments

    (2,645 )     (14,890

)

Proceeds from maturities of short-term investments

    10,000       20,000  

Capital expenditures for property and equipment

    (66 )     (168

)

Investment in patents and trademarks

    (176 )     (102 )

Purchase of intangible assets

    (10 )     -  

Investment in long-term deposits

    -       (2

)

Proceeds from long-term deposits

    31       -  

Net cash provided by investing activities

    7,134       4,838  
                 

Cash Flows From Financing Activities:

               

Proceeds from exercise of stock options

    -       75  

Net cash provided by financing activities

    -       75  
                 
Net decrease in cash and cash equivalents     6,358       (1,294

)

Cash and cash equivalents, beginning of period

    5,330       4,937  

Cash and cash equivalents, end of period

  $ 11,688     $ 3,643  
                 

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

               

Change in unrealized gain on short-term investments

  $ (94 )   $ (11

)

Right-of-use asset and liability recorded during period

  $ -     $ 335  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

 

Wrap Technologies, Inc.

Notes to Unaudited Condensed Consolidated Interim Financial Statements

(in thousands, except per share and share amounts)

 

 

1.                ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Business Description

 

Wrap Technologies, Inc., a Delaware corporation (the “Company”, “we”, “us”, and “our”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“Common Stock”), listed on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.

 

Basis of Presentation

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022, has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

 

Principles of Consolidation

 

The Company has one wholly-owned subsidiary, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“VR”) training system primarily targeting law enforcement agencies. The consolidated financial statements include the accounts of this subsidiary after elimination of intercompany transactions and accounts.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.

 

Loss per Share

 

Basic loss per common share is computed by dividing net loss for the period by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss per Common Share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential Common Stock instruments outstanding to be antidilutive. Stock options and restricted stock units exercisable or issuable for a total of 4,117,586 and 6,458,823 shares of Common Stock were outstanding at June 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.

 

 

Recent Issued Accounting Guidance

 

The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

 

 

2.          REVENUE AND PRODUCT COSTS

 

Revenue consists of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenue, service, training and shipping revenue.

 

Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service.

 

The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the six months ended June 30, 2023.

 

 

   

Customer

   

Deferred

 
   

Deposits

   

Revenue

 

Balance at January 1, 2023

  $ -     $ 333  

Additions, net

    3       124  

Transfer to revenue

    -       (117 )

Balance at June 30, 2023

  $ 3     $ 340  

Current portion

  $ 3     $ 211  

Long-term portion

  $ -     $ 129  

 

At June 30, 2023, the Company’s deferred revenue of $340 consisted of $217 related to VR, $17 related to training and $106 related to BolaWrap extended warranties and services. At December 31, 2022, the Company’s deferred revenue of $333 consisted of $198 related to VR, $11 related to training and $124 related to BolaWrap extended warranties and services.

 

Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to cost of products sold.

 

 

3.          FINANCIAL INSTRUMENTS

 

Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

The Company’s cash equivalent Money Market Funds and short-term investments consisting of U.S. Treasury bill securities and Certificate of Deposits are classified as Level 1 because they are valued using quoted market prices.

 

The following table shows the Company’s cash and cash equivalents, Money Market Funds and short-term investments by significant investment category as of June 30, 2023, and December 31, 2022.

 

   

As of June 30, 2023

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Money Market Funds

  $ 2,774     $ -     $ -     $ 2,774  

U.S. Treasury securities in short-term investments

    -       -       -       -  
Certificate of Deposits     6,500       -       -       6,500  

Total Financial Assets

  $ 9,274     $ -     $ -     $ 9,274  

 

   

As of December 31, 2022

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Money Market Funds

  $ 3,004     $ -     $ -     $ 3,004  

U.S. Treasury securities in short-term investments

    9,849       100       -       9,949  

Certificate of Deposits

    4,000       -       -       4,000  

Total Financial Assets

  $ 16,853     $ 100     $ -     $ 16,953  

 

Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss as they are classified as available for sale. During the three and six months ended June 30, 2023, a $0 gain and $0 loss was recorded to accumulated other comprehensive gain (loss), respectively. During the three and six months ended June 30, 2022, a $12 gain and $11 loss was recorded to accumulated other comprehensive gain (loss), respectively.

 

Our financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

 

 

4.          INVENTORIES

 

Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following:

 

   

June 30,

2023

   

December 31,

2022

 

Finished goods

  $ 3,793     $ 2,293  

Work in process

    -       -  

Raw materials

    2,727       1,682  

Inventories - net

  $ 6,520     $ 3,975  

 

 

 

5.          PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 

   

June 30,

2023

   

December 31,

2022

 

Production and lab equipment

  $ 506     $ 513  

Tooling

    490       448  

Computer equipment

    561       531  

Furniture, fixtures and improvements

    181       181  
      1,738       1,673  

Accumulated depreciation

    (1,150 )     (915 )

Property and equipment, net

  $ 588     $ 758  

 

Depreciation expense was $118 and $236 for the three and six months ended June 30, 2023, respectively, and $124 and $237 for the three and six months ended June 30, 2022, respectively.

 

 

6.          INTANGIBLE ASSETS, NET

 

Intangible assets consisted of the following:

 

   

June 30,

2023

   

December 31,

2022

 

Amortizable intangible assets:

               

Patents

  $ 744     $ 575  

Trademarks

    157       150  

Purchased software

    1,962       1,962  
      2,863       2,687  

Accumulated amortization

    (629 )     (462 )

Total amortizable

    2,234       2,225  

Indefinite life assets (non-amortizable)

    354       344  

Total intangible assets, net

  $ 2,588     $ 2,569  

 

Amortization expense was $85 and $167 for the three and six months ended June 30, 2023, respectively, and $73 and $143 for the three and six months ended June 30, 2022, respectively.

 

At June 30, 2023, future amortization expense is as follows:

 

2023 (9 months)

  $ 259  

2024

    518  

2025

    513  

2026

    290  

2027

    42  

Thereafter

    612  

Total estimated amortization expense

  $ 2,234  

 

 

7.          ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable includes $40 and $127 due to related party Syzygy Licensing, LLC (“Syzygy”) as of June 30, 2023 and December 31, 2022, respectively. See Notes 11 for additional information on this related party.

 

The Company consummated an offering of Series A Convertible Preferred Stock and Warrants (“Offering”), which Offering closed on July 5, 2023, resulting in gross proceeds to the Company of approximately $10 million of which $7.4 million was received on June 29, 2023. The $7.4 million received was recorded to cash with an offset to accrued expense.

 

Accrued liabilities consist of the following:

 

   

June 30,

2023

   

December 31,

2022

 

Patent and legal costs

  $ 103     $ 135  

Accrued compensation

    777       1,100  

Warranty costs

    75       125  
Pre-funding of the sale of shares, preferred stock and warrants     7,350       -  

Taxes and other

    257       103  
Total   $ 8,562     $ 1,463  

 

 

Accrued compensation includes $80 and $1,022 in employee bonuses and commissions payable at June 30, 2023 and December 31, 2022, respectively.

 

Changes in our estimated product warranty costs were as follows:

 

   

Six Months Ended

June 30,

 
   

2023

   

2022

 

Balance, beginning of period

  $ 125     $ 96  

Warranty settlements

    (6 )     (63 )

Warranty provision

    (44 )     45  

Balance, end of period

  $ 75     $ 78  

 

 

8.          STOCKHOLDERS' EQUITY

 

The Company’s authorized capital consists of 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred Stock”).

 

 

9.          SHARE-BASED COMPENSATION

 

On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019, the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock; in June 2020 ratified an additional 1,900,000 shares of Common Stock; in June 2021 ratified an additional 1,500,000 shares of Common Stock; and in June 2022 ratified an additional 1,500,000 shares of Common Stock; for a total of 9,000,000 shares subject to the Plan. At June 30, 2023, there were 2,848,936 shares of Common Stock remaining available for grant under the Plan.

 

The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In April 2023 the Company recognized severance acceleration of $178 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer and Chief Operating Officer due to a reduction in force that resulted in changes in the composition of the executives of the Company. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.

 

Stock Options

 

The following table summarizes stock option activity for the six months ended June 30, 2023:

 

           

Weighted Average

         
   

Options on

Common

Shares

   

Exercise

Price

   

Remaining

Contractual

Term

   

Aggregate

Intrinsic

Value

 

Outstanding January 1, 2023

    5,491,399     $ 3.72       5.96     $ 92  

Granted

    60,000     $ 1.34                  

Exercised

    (250 )   $ 1.5                  

Forfeited, cancelled, expired

    (1,982,900 )   $ 4.14                  

Outstanding June 30, 2023

    3,568,249     $ 3.37       8.08     $ 7  

Exercisable June 30, 2023

    1,052,714     $ 4.56       6.79     $ 0  

 

 

At June 30, 2023, there were 1,954,019 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 3,568,249 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant, but are subject to the terms and conditions of the Plan.

 

The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:

 

   

For the Six Months

 
   

Ended June 30,

 
   

2023

   

2022

 

Expected stock price volatility

    49

%

    49

%

Risk-free interest rate

    3.64

%

    1.09

%

Expected life of options

    6.66       1.82  
Weighted-average fair value of options granted   $ 0.55     $ 1.32  

 

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.

 

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.

 

The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years.

 

Stock option expense was $255 and $567 for the three and six months ended June 30, 2023, respectively, and $408 and $1,145 for the three and six months ended June 30, 2022, respectively.

 

Restricted Stock Units

 

The Plan provides for the grant of restricted stock units (“RSUs”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the six months ended June 30, 2023:

 

   

Service-Based

RSU's

   

Weighted

Average

Grant Date

Fair Value

   

Weighted

Average

Vesting

Period

(Years)

 

Unvested at January 1, 2023

    922,057     $ 2.88       2.11  

Granted - service based

    625,896     $ 1.31          

Vested

    (734,444 )   $ 2.87          

Forfeited and cancelled

    (264,172 )   $ 2.49          

Unvested at June 30, 2023

    549,337     $ 2.03       1.88  

 

 

RSU expense was $966 and $1,282 for the three and six months ended June 30, 2023, respectively, and $319 and $611 for the three and six months ended June 30, 2022, respectively.

 

Share-Based Compensation Expense

 

The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:

 

   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
   

2023

   

2022

   

2023

   

2022

 

Selling, general and administrative

  $ 990     $ 591     $ 1,552     $ 1,485  

Research and development

    231       136       297       271  

Total share-based expense

  $ 1,221     $ 727     $ 1,849     $ 1,756  

 

As of June 30, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $2,609 which is expected to be recognized over the weighted average period of 3.12 years.

 

As of June 30, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,115 which is expected to be recognized over the weighted average period of 1.82 years.

 

 

10.          DEFINED CONTRIBUTION PLAN

 

The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for each of the three and six months ended June 30, 2023 and year ended December 31, 2022 was $0.

 

 

11.          COMMITMENTS AND CONTINGENCIES

 

Related Party Technology License Agreement

 

The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026, whichever occurs earlier. The Company recorded $40 and $64 for royalties during the three and six months ended June 30, 2023, respectively, and $34 and $83 for royalties during the three and six months ended June 30, 2022, respectively. The maximum payout still available under this arrangement is $217 as of June 30, 2023.

 

Service Provider Agreement

 

Pursuant to the Professional Services and Technology Acquisition Agreement (the “Agreement”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “Service Provider”) on November 22, 2022, as amended on April 2, 2023, the Service Provider is to provide to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “Technology, Services, and License”) in consideration for a cash payment of $700 to the Service Provider.

 

Purchase Commitments

 

At June 30, 2023, the Company was committed for approximately $3,878 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.

 

 

Indemnifications and Guarantees

 

Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities.

 

Regulatory Agencies

 

The Company is subject to oversight from regulatory agencies regarding firearms that arises in the ordinary course of its business.

 

Litigation

 

Shareholder Derivative Litigation

 

On November 13, 2020, Naresh Rammohan filed a shareholder derivative action in the US District Court for the Central District of California against current and former Company officers as well as current and former Company directors alleging unjust enrichment, breach of fiduciary duty, waste of corporate assets, and contribution claims under the Securities Exchange Act of 1934, docketed as Case No. 2:20-cv-10444-DMG-PVCx. The derivative action was dismissed with prejudice by stipulation of the parties on May 3, 2022.

 

 

12.          RELATED PARTY TRANSACTIONS

 

Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer, current 10% stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $4.5 and $9 during the three and six months ended June 30, 2023, and 2022, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective June 30, 2021, and commencing July 1, 2021, was engaged as a month-to-month consultant. Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $22.5 and $45 during each of the three and six months ended June 30, 2023 and 2022.

 

See Notes 7, 11 and 14 for additional information on related party transactions and obligations.

 

 

13.          MAJOR CUSTOMERS AND RELATED INFORMATION

 

For the three months ended June 30, 2023, revenue from two distributors accounted for approximately 21% and 21% of revenue with no other single customer accounting for more than 10% of total revenue. For the three months ended June 30, 2022, revenue from three distributors and one agency accounted for approximately 24%, 18%, 12% and 11% of revenue with no other single customer accounting for more than 10% of total revenue.

 

For the six months ended June 30, 2023, revenue from three distributors accounted for approximately 15%, 14% and 13% of revenue with no other single customer accounting for more than 10% of total revenue. For the six months ended June 30, 2022, revenue from one distributor accounted for approximately 25% of revenue with no other single customer accounting for more than 10% of total revenue.

 

At June 30, 2023, accounts receivable from three distributors accounted for 22%, 13% and 13% of net accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. At December 31, 2022, accounts receivable from one distributor accounted for 70% of net accounts receivable.

 

The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer’s delivery location:

 

   

For the Three Months

   

For the Six Months

 
   

Ended June 30,

   

Ended June 30,

 
   

2023

   

2022

   

2023

   

2022

 

Americas

  $ 1,168     $ 1,090     $ 1,878     $ 2,285  

Europe, Middle East and Africa

    35       73       36       247  

Asia Pacific

    (1 )     2       (1 )     232  
Total   $ 1,202     $ 1,165     $ 1,913     $ 2,764  

 

 

 

14.          SUBSEQUENT EVENTS

 

Registered Direct Offering

 

On June 29, 2023, the Company entered into a Securities Purchase Agreement with a founder and director of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a registered direct offering (the “Offering”) (i) an aggregate of 10,000 shares of the Company’s newly-designated Series A Convertible Preferred Stock, with a par value $0.0001 per share, and a stated value of $1,000 per share (“Series A Preferred”), initially convertible into up to 6,896,553 shares of the Company’s Common Stock, at a conversion price of $1.45 per share, and (ii) warrants to acquire up to an aggregate of 6,896,553 shares of Common Stock (“Warrants”). The Series A Preferred provide for the payment to holders thereof of cumulative dividends of 8% per annum, payable quarterly in arrears. The Warrants are exercisable six months after issuance at an exercise price of $1.45 per share, subject to adjustment, and expire five years from the date of issuance. The $1.45 per share conversion price of the Series A Preferred and exercise price of the Warrant represent the closing share price of the Company’s Common Stock on June 29, 2023. The Offering closed on July 5, 2023 (the “Closing”), resulting in aggregate gross proceeds from the Offering of approximately $10 million.

 

Although the Closing occurred subsequent to June 30, 2023, the Company received approximately $7.35 million in gross proceeds from the Offering on June 30, 2023 following the execution of the Securities Purchase Agreement and prior to the Closing, which amount is reflected in cash and cash equivalents, with an offset to accrued expense, each as reflected in the Company’s Condensed Consolidated Balance Sheet at June 30, 2023. At the Closing, the Company received additional gross proceeds from the Offering of approximately $2.65 million. After payment of placement agent fees and costs of the Offering, the net proceeds from the Offering were approximately $9 million. The Company intends to allocate the proceeds from the Offering to scale the Company’s sales team, support marketing efforts, and fuel the evolution and diversification of the Company’s product offerings.

 

The Company has evaluated other events subsequent to June 30, 2023 through the date the accompanying financial statements were filed with the Securities and Exchange Commission and noted that, other than as set forth above, there have been no other events or transactions which would affect the Company’s financial statements for the quarter ended June 30, 2023.

 

Acquisition of Intrensic, LLC

 

On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Intrensic, LLC, a Delaware limited liability company (“Intrensic”), and certain members of Intrensic, including Kevin Mullins, the Company’s Chief Executive Officer (collectively, “Sellers”). Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “Membership Interests”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests (the “Intrensic Closing”): (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Intrensic Closing; and (ii) 1,250,000 shares of Common Stock of the Company (collectively, the “Purchase Price”) (the “Intrensic Acquisition”).

 

The Purchase Agreement contains representations, warranties and covenants of the Company and Sellers that are customary for a transaction of this nature, a customary indemnification provisions whereby Sellers will indemnify the Company for certain losses arising out of inaccuracies in, or breaches of, the representations, warranties and covenants of Sellers regarding Intrensic, ownership of the Membership Interest, and certain other matters, subject to certain caps and thresholds.

 

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by the full text of the Purchase Agreement, a copy of which is filed as an exhibit to this Quarterly Report and is incorporated by reference in this description of the Purchase Agreement.

 

Kevin Mullins, a director of the Company and the Company’s Chief Executive Officer, owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the Intrensic Acquisition.

 

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion in conjunction with the financial statements and other financial information included elsewhere in this Quarterly Report on Form 10-Q (this Report) and with our audited financial statements and other information presented in our Annual Report on Form 10-K for the year ended December 31, 2022 (the Annual Report). The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs. Words such as expect, anticipate, intend, plan, believe, seek, estimate, continue, may, will, could, would, or the negative or plural of such words and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the only means of identifying forward-looking statements. Such forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those discussed below and elsewhere in this Report and in our other filings with the Securities and Exchange Commission (SEC), including particularly matters set forth under Part I, Item 1A (Risk Factors) of the Annual Report. Furthermore, such forward-looking statements speak only as of the date of this Report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. For purposes of Management's Discussion and Analysis within this Report, all monetary amounts are stated in thousands except for par values and per share amounts, unless otherwise stated.

 

Overview

 

We are a global public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. We are leading the movement for safer outcomes by equipping law enforcement with safe, non-pain compliance tools and immersive training for the modern world. We began sales of our first public safety product, the BolaWrap 100 remote restraint device, in late 2018. In late 2020 we added a new solution to our public safety technologies, which is our virtual reality (“VR”) training platform – Wrap Reality. Wrap Reality is now sold to law enforcement agencies for simulation training as well as corrections departments for the societal reentry scenarios. In Q1 2022 we delivered a new generation product, the BolaWrap 150. The BolaWrap 150 is electronically deployed and is more robust, smaller, lighter and simpler to deploy than the BolaWrap 100 that has been phased out.

 

Our target market for our solutions includes approximately 900,000 full-time sworn law enforcement officers in over 18,000 federal, state, and local law enforcement agencies in the U.S. and over 12 million police officers in more than 100 countries. Additionally, we are exploring opportunities in other domestic markets, such as military and private security. Our international focus is on countries with the largest police forces. According to 360iResearch, a market research consulting firm, our non-lethal products are part of a global market segment expected to grow to $16.1 billion by 2027.

 

We focus our efforts on the following products and services:

 

BolaWrap Remote Restraint Device – is a hand-held remote restraint device that discharges a seven and half-foot Kevlar tether to entangle an individual at a range of 10-25 feet. BolaWrap assists law enforcement to safely and effectively control encounters early without resorting to painful force options.

 

Wrap Reality – is a law enforcement 3D training system employing immersive computer graphics VR with proprietary software-enabled content. It allows up to two participants to enter a simulated training environment simultaneously, and customized weapons controllers enable trainees to engage in strategic decision making along the force continuum. Wrap Reality has 38 scenarios for law enforcement and corrections and 25 scenarios at this time for societal reentry. Wrap Reality is one of the most robust 3D Virtual Reality solutions on the market for law enforcement and societal reentry today.

 

In addition to the US law enforcement market, we have shipped our restraint products to 62 countries. We have established an active distributor network representing 50 states and one dealer representing the US territory of Puerto Rico. We have distribution agreements with 49 international distributors covering 54 countries. We focus significant sales, training and business development efforts to support our distribution network in addition to our internal sales team.

 

We focus significant resources on research and development innovations and continue to enhance our products and plan to introduce new products. We believe we have established a strong brand and market presence globally and have established significant competitive advantages in our markets.

 

 

Management Changes

 

On April 17, 2023, Kevin Mullins was named Chief Executive Officer.  In connection with Mr. Mullins' appointment, TJ Kennedy agreed to immediately step down as the Company’s Chief Executive Officer and a member of the Board of Directors (the “Board”).  Additionally, on April 17, 2023, the Company performed a reduction in force that resulted in changes in the composition of the executives of the Company.  As part of the reduction in force, Glenn Hickman stepped down as Chief Operating Officer.

 

Business Outlook and Challenges

 

We believe our Company's products and solutions are gaining global recognition and awareness through active use across multiple agencies and continued acceptance worldwide as well as various marketing channels such as demos, social media, trade shows, and media exposure, among others. In part, this recognition and awareness can be attributed to positive feedback from law enforcement agencies and the successful deployment of our products. As a result, our brand, Wrap, is becoming increasingly recognized on a global scale as a leader in remote restraint and non-lethal solutions.

 

In addition, we are focused on aggressive marketing and public relations efforts. We are confident in the potential market opportunities for our remote restraint and virtual reality solutions in the law enforcement and security sectors worldwide. These opportunities are driven by the increasing demand for less-lethal policing.

 

In the law enforcement sector, our BolaWrap product has been successfully deployed in the field, as reported by agencies worldwide. BolaWrap is now in use by almost 1,000 US law enforcement agencies and in 62 countries. Due to its safe remote restraint capabilities, many agencies do not deem its usage a categorical reportable use of force and rather place it underneath early use of force such as handcuffs. We train law enforcement agencies deploy BolaWrap when verbal commands breakdown but long before there is justifiable escalation to pain inducing tools such as: pepper spray, pepper ball, batons, bean bags, tasers or Conducted Electrical Weapons (CEW’s) or firearms.

 

Agencies voluntarily report usage to Wrap. In the usage reports we have been provided; officers have reported successful outcomes in 83% of the use cases. This percentage is higher than what is often seen with less lethal tools. From the information we have been provided, the most common BolaWrap use case is for individuals with behavioral health issues, and the second most common BolaWrap use case is during domestic violence calls. Twenty-six percent of the reported persons who are wrapped with the BolaWrap are thought to be under the influence of alcohol or drugs.

 

There are many reasons why we may not receive reports on all the use of the BolaWrap, including, when uses of BolaWrap are considered evidence in ongoing criminal cases, are controlled by local policy or regulation, or require officer and union and other released to be shared with us. However, many agencies have shared bodycam footage of successful field deployments with us, which we may use in our training and education efforts. We believe that as the reports of BolaWrap's effectiveness in de-escalation continue to increase, it will contribute to our future revenue growth.

 

Management anticipates that our portfolio of safe, remote restraint products and training tools has a strong and expanding pipeline of market opportunities in the law enforcement, military, corrections, and homeland security sectors both domestically and internationally. With the increasing demand for more humane and safer policing practices, we expect a continued surge in our global business. Currently, we are exploring major international business prospects while simultaneously seeking to establish relationships with large police agencies in the U.S. However, we acknowledge that it is challenging to predict the exact timeline for closing these deals, or whether they will ultimately materialize.

 

As part of our efforts to expand our sales and distribution operations, we provide a comprehensive training program for law enforcement officers and trainers in using the BolaWrap. This training equips them with knowledge about the appropriate use and limitations of BolaWrap in tandem with modern policing techniques for de-escalation of encounters. We now focus on also teaching when and why BolaWrap should be used, including the specific area of success (i.e., after verbal commands break down and before the law enforcement officer is ready to escalate to pain compliance tools. Management believes that law enforcement trainers and officers who have been trained to use our products, or have witnessed demonstrations, are more inclined to support the acquisition and deployment of our products by their respective departments to drive successful outcomes. As of June 30, 2023, over 1,450 agencies have received BolaWrap training with over 4,827 training officers at those agencies certified as BolaWrap instructors and qualified to train the rest of their departments, representing a 18% increase in agencies and a 16% increase in trained officers as compared to June 30, 2022. 

 

 

Operating expense for the second quarter of fiscal 2023 increased $0.51 million, or 10%, to $5.75 million from $5.24 million in the prior year period. The increase in operating expense was the result of the Company incurring approximately $1.4 million of one-time items related to organizational changes including severance and legal fees that impacted operational expense. Excluding these one-time items, operational expense for the second quarter 2023 would have been $4.35 million or a 17% decrease from the prior year period. We expect to see the full benefit of the organizational changes we made in April during the back half of 2023.

 

Management is confident that implementing the strategic changes it made in April will lead to substantial sales growth and put us on a path towards sustainable profitability. Although geopolitical tensions and macroeconomic challenges have affected our quarterly results in the past and may in the future, we believe our firm is uniquely positioned to provide lifesaving technologies and training that enable law enforcement officers worldwide to conduct safe and effective encounters while reducing the use of force. If departments follow our Use of Force Guarantee requirements, we are confident enough to offer that in 12 months we would buy their BolaWrap devices back if they do not reduce their reportable use of force by 10%. With an increasing addressable market, Wrap offers a unique value proposition. Our improved pricing strategy, coupled with reduced operating expense and our growing sales outlook, is expected to help reduce losses and improve cash flow in the future. 

 

Looking ahead to the coming years, we plan to increase the number of product demonstrations and training sessions, particularly in international markets. Our new focus on the when and why BolaWrap is used is already showing improved results. This is a departure of the hardware product only approach of the past. Our sales of the BolaWrap 150 and Wrap Reality are expected to continue to rise, aided by our ongoing cost savings and cost control measures, which should lead to an overall reduction in cash burn.

 

At June 30, 2023 we had backlog of approximately $25 thousand expected to be delivered in the third quarter of 2023. Additionally, we had deferred revenue of $340 thousand expected to be recognized generally over the next five years. Our deferred revenue mostly is from Wrap Reality subscription and other revenue. We expect our deferred revenue to grow in future years due to the SaaS business model on Wrap Reality. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instances, cancellation, in the normal course of business.

 

Since inception, we have generated significant losses from operations and anticipate that we will continue to generate significant losses from operations for the foreseeable future. We believe that we have adequate financial resources to sustain our operations for the next year. We increased our net loss during the second quarter of fiscal 2023 by more than $0.2 million as compared to the second quarter of fiscal 2022. The decrease in net loss was primarily the result of one-time items related to the organizational changes made during the second quarter 2023 including $1.4 million of non-cash expense related to stock compensation, severance, and legal fees. Excluding the one-time items, net loss for the second quarter 2023 would have been $3.61 million or a 25% decrease from the prior year period. Net cash used in operations during the six months ended June 30, 2023 was $5.43 million less than cash used in operations during the six months ended June 30, 2022. This improvement was a result of our strategic roadmap as well as our cost control measures implemented in Q2, Q3 and Q4 of our last fiscal year, and Q1 and Q2 of this fiscal year.

 

We expect that we will continue to innovate new applications for our public safety technology, open new geographies, develop new products and technologies to meet diverse customer requirements and identify and develop new markets for our products. We believe that our sales during the second quarter of fiscal 2023 were impacted by the timing of new orders, particularly on in the international market, and associated budgeting from our customers. 

 

Supply chain disruptions have affected our operations in the past and could negatively impact our ability to source materials, manufacture and distribute products in the future. Moreover, financial markets have continued to experience significant volatility, challenging the Company’s ability to access the capital markets to provide additional working capital to fund the Company’s growth. Despite these conditions, and following an analysis of our future capital needs, the Company consummated an offering of Series A Convertible Preferred Stock and Warrants (“Offering”), which Offering closed on July 5, 2023, resulting in gross proceeds to the Company of approximately $10 million of which $7.4 million was received on June 29, 2023. The $7.4 million received was recorded to cash with an offset to accrued expense. As a result, we had $18.2 million in cash and cash equivalents and short-term investments as of June 30, 2023. We therefore believe we have sufficient capital to fund our operations for the next twelve months. However, liquidity constraints and access to capital markets could still negatively affect our liquidity and require changes to our investment strategy.

 

 

Future global pandemics could potentially result in lost or delayed revenue for our Company, as occurred in the years ended December 31 2021 and 2022 due to the global COVID-19 pandemic. These potential future events could include restrictions on our suppliers' ability to meet delivery requirements and commitments, employees' inability to perform their work due to illness caused by a pandemic or local, state, or federal mandates requiring employees to stay home. Delays in carriers' ability to deliver our products to customers, unforeseen deviations from customers or foreign governments restricting the ability to conduct business, and customers' inability to pay us on a timely basis, if at all, could also limit our revenue.

 

Our Company may be positively or negatively impacted by social unrest, protests against racial inequality, and movements like "Defund the Police." Such unrest may be further fueled by misleading information or negative publicity about our solutions. We believe our solutions are actually the answer to reducing use of force and driving safer outcomes for officers and the citizens they interact with each day. Although the intensity of these events may have subsided, some may still indirectly or directly influence police agency budgets and the funding available to current and potential customers. In addition, participants in these events may attempt to create the impression that our solutions are contributing to the perceived problems, potentially harming our business and operations, including our revenue, earnings, and cash flows from operations.

 

Changes in our management and other critical personnel have the potential to negatively affect our business. Such disruptions could have an adverse impact on our operations, programs, growth, financial condition, or results of operations. On the other hand, improvements in our operations, operating expense, and go-to-market approaches could positively influence the success of our business in the future.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. We evaluate our estimates, on an on-going basis, including those estimates related to recognition and measurement of contingencies and accrued expense. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

As part of the process of preparing our financial statements, we are required to estimate our provision for income taxes. Significant management judgment is required in determining our provision for income taxes, deferred tax assets and liabilities, tax contingencies, unrecognized tax benefits, and any required valuation allowance, including taking into consideration the probability of the tax contingencies being incurred. Management assesses this probability based upon information provided by its tax advisers, its legal advisers and similar tax cases. If later our assessment of the probability of these tax contingencies changes, our accrual for such tax uncertainties may increase or decrease. Our effective tax rate for annual and interim reporting periods could be impacted if uncertain tax positions that are not recognized are settled at an amount which differs from our estimates.

 

Some of our accounting policies require higher degrees of judgment than others in their application. These include share-based compensation and contingencies and areas such as revenue recognition, allowance for doubtful accounts, valuation of inventory and intangible assets, estimates of product line exit costs, warranty liabilities and impairments.

 

Revenue Recognition. We sell our products to customers including law enforcement agencies, domestic distributors and international distributors and revenue from such transactions is recognized in the periods that products are shipped (free on board (“FOB”) shipping point) or received by customers (FOB destination), when the fee is fixed or determinable and when collection of resulting receivables is reasonably assured. We identify customer performance obligations, determine the transaction price, allocate the transaction price to the performance obligations and recognize revenue as we satisfy the performance obligations. Our primary performance obligations are products/accessories and VR software licensing or sale. Our customers do not have the right to return product unless the product is found to be defective.

 

 

Share-Based Compensation. We follow the fair value recognition provisions issued by the Financial Accounting Standards Board (“FASB”) in Accounting Standards Codification (“ASC”) Topic 718, Stock Compensation (“ASC 718”) and we adopted Accounting Standards Update (“ASU”) 2018-07 for share-based transactions with non-employees. Share-based compensation expense recognized includes stock option and restricted stock unit compensation expense. The grant date fair value of stock options is determined using the Black-Scholes option-pricing model. The grant date is the date at which an employer and employee or non-employee reach a mutual understanding of the key terms and conditions of a share-based payment award. The Black-Scholes option-pricing model requires inputs including the market price of the Company’s Common Stock on the date of grant, the term that the stock options are expected to be outstanding, the implied stock volatilities of several publicly traded peers over the expected term of stock options, risk-free interest rate and expected dividend. Each of these inputs is subjective and generally requires significant judgment to determine. The grant date fair value of restricted stock units is based upon the market price of the Company’s Common Stock on the date of the grant. We determine the amount of share-based compensation expense based on awards that we ultimately expect to vest and account for forfeitures as they occur. The fair value of share-based compensation is amortized to compensation expense over the vesting term.

 

Allowance for Doubtful Accounts. Our products are sold to customers in many different markets and geographic locations. We estimate our bad debt reserve on a case-by-case basis and the aging of accounts due to a limited number of customers mostly government agencies or well-established distributors. We base these estimates on many factors including customer credit worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment terms. Our judgments and estimates regarding collectability of accounts receivable have an impact on our financial statements.

 

Valuation of Inventory. Our inventory is comprised of raw materials, assemblies and finished products. We must periodically make judgments and estimates regarding the future utility and carrying value of our inventory. The carrying value of our inventory is periodically reviewed and impairments, if any, are recognized when the expected future benefit from our inventory is less than carrying value.

 

Valuation of Intangible Assets. Intangible assets consisted of (a) capitalized legal fees and filing expense related to obtaining patents and trademarks, (b) customer agreements, tradenames, software, non-solicitation and non-compete agreements acquired in business combinations and valued at fair value at the acquisition date, and (c) the purchase cost of indefinite-lived website domains. We must make judgments and estimates regarding the future utility and carrying value of intangible assets. The carrying values of such assets are periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than carrying value. This generally could occur when certain assets are no longer consistent with our business strategy and whose expected future value has decreased.

 

Accrued Expense. We establish a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. This reserve requires us to make estimates regarding the amount and costs of warranty repairs we expect to make over a period of time. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs, and anticipated rates of warranty claims. We have very limited history to make such estimates and warranty estimates have an impact on our financial statements. Warranty expense is recorded in cost of revenue. We evaluate the adequacy of this reserve each reporting period.

 

We use the recognition criteria of FASB ASC Topic 450-20, Loss Contingencies, to estimate the amount of bonuses when it becomes probable a bonus liability will be incurred and we recognize expense ratably over the service period. We accrue bonus expense each quarter based on estimated year-end results, and then adjust the actual in the fourth quarter based on our final results compared to targets.

 

Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. Other than the planned production change requiring a new estimate of exit expense, there were no significant changes or modification of our critical accounting policies and estimates involving management valuation adjustments affecting our results for the period ended June 30, 2023. Our accounting policies are more fully described in Note 1. Organization and Summary of Significant Accounting in the notes to our audited consolidated financial statements included in the Annual Report.

 

 

Recent Accounting Pronouncements

 

New pronouncements issued for future implementation are discussed in Note 1. Organization and Summary of Significant Accounting Policies of our financial statements.

 

Segment and Related Information

 

The Company operates as a single segment. The Company’s chief operating decision maker is its Chief Executive Officer, who manages operations for purposes of allocating resources. Refer to Note 13. Major Customers and Related Information, in our financial statements for further discussion.

 

Operating Expense

 

Our operating expense includes (i) selling, general and administrative expense, (ii) research and development expense, and in the most recent fiscal quarter, (iii) product line exit expense. Research and development expense is comprised of the costs incurred in performing research and development activities and developing production on our behalf, including compensation and consulting, design and prototype costs, contract services, patent costs and other outside expense. The scope and magnitude of our future research and development expense is difficult to predict at this time and will depend on elections made regarding research projects, staffing levels and outside consulting and contract costs. The future level of selling, general and administrative expense will be dependent on staffing levels, elections regarding expenditures on sales, marketing and customer training, the use of outside resources, public company and regulatory expense, and other factors, some of which are outside of our control.

 

We expect our operating costs will reduce from the first half of 2023 as a result of the changes implemented in April 2023, and ongoing cost containment efforts. We may incur additional non-cash share-based compensation costs depending on future option and restricted stock unit grants that are impacted by stock prices and other valuation factors. Historical expenditures are not indicative of future expenditures.

 

Results of Operations

 

Three Months Ended June 30, 2023 Compared to Three Months Ended June 30, 2022

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Three Months Ended

June 30,

   

Change

 
   

2023

   

2022

   

$

   

%

 

Revenue:

                               

Product sales

  $ 1,034     $ 969     $ 65       7

%

Other revenue

    168       196       (28

)

    (14

)%

Total revenue

    1,202       1,165       37       3

%

Cost of revenue

    534       708       (174

)

    (24

)%

Gross profit

    668       457       211       46

%

                                 

Operating expense:

                               

Selling, general and administrative

    4,745       3,764       981       26

%

Research and development

    1,002       1,476       (474

)

    (32

)%

Total operating expense

    5,747       5,240       507       10

%

Loss from operations

  $ (5,079

)

  $ (4,783

)

  $ (296

)

    6

%

 

Revenue

 

We reported net revenue of $1.2 million for the three months ended June 30, 2023, as compared to $1.2 million for the quarter ended June 30, 2022, a 3% increase over the prior year. International revenue decreased from $75 thousand for the three months ended June 30, 2022 to $31 thousand for the three months ended June 30, 2023. We believe that our sales during the three months ended June 30, 2023, were impacted by the timing of new orders, particularly international and associated budgeting from our customers. We also incurred discounts of $42 thousand during the three months ended June 30, 2023, as a result of promotional programs designed to encourage customers to upgrade to the BolaWrap 150. Gross sales were $1.2 million for the three months ended June 30, 2023, before such discounts. The discounts compare to normal business discounts of $161 thousand in the comparable quarter of the prior year. We expect a decline to minimal discounts in 2023 as we have phased out our promotional upgrade offer.

 

 

International revenue generally consists of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. International orders anticipated in the second quarter of 2022 were delayed significantly due to the changeover from the BolaWrap 100 but those orders for BolaWrap 150 are anticipated in future quarters. We believe that revenue during the fiscal year 2023 will increase overall compared to the revenue recorded during 2022 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given. We believe based on pipeline that these larger international deals are more likely to book and ship in the latter half of 2023.

 

We incurred product promotional costs of $41 thousand during the three months ended June 30, 2023, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. We are responding to increased demand for training as a result of expanded product and brand awareness and increased successful field use by agencies but due to awareness expect reductions in product promotional costs from the prior year.

 

We had $340 thousand of deferred revenue at June 30, 2023, of which $217 thousand related to VR, $17 thousand was related to training and $106 thousand related to BolaWrap extended warranties and services. As we potentially secure increased bookings for Wrap Reality, as well as BolaWrap extended warranties, we expect our deferred revenue to grow in future quarters.

 

At June 30, 2023, we had backlog of $25 thousand expected to be delivered in the third quarter of 2023. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instance’s cancellation in the normal course of business. 

 

Gross Profit

 

Our gross profit for the three months ended June 30, 2023 was $668 thousand, or a gross margin of 56%. Our cost of revenue for the three months ended June 30, 2022 was $457 thousand resulting in a gross margin of 39%. The increase in gross profit represented an 46% increase over prior year as a result of rolling out the BolaWrap 150 product, selling price adjustments implemented in September of 2022, and a reduction of promotional pricing, offset by some supply chain issues and inventory adjustments.

 

As our revenue history is limited, historical margins may not accurately reflect future margins. However, we expect higher margins with the production of the BolaWrap 150 compared to previous production due to design changes and improved pricing. Our margins are also subject to variations based on the sales channels and product mix through which our products are sold. At present, our cassettes have lower margins than BolaWrap devices. As we scale cassette production, we will look to reduce our costs and drive higher cassette margins. Cassettes were a total of 19% of our overall revenue in the three months ended June 30, 2023, and will continue to grow as a recurring revenue base as more BolaWrap devices are in the field and the usage of BolaWrap increases due to the need of officers to de-escalate earlier to prevent injuries and use of higher levels of force.

 

We regularly introduce updates and revisions to our products, which may include changes to raw materials and components, and can impact our product costs. Given our limited experience with warranty costs, our estimated future warranty expense may affect our gross margins.

 

Our global supply chain has experienced notable component shortages, extended lead times, cost fluctuations, and logistical constraints, all of which have affected our product costs. Although we have seen these supply chain obstacles ease in 2023, we acknowledge that future supplier shortages, quality problems, and logistics delays could impact our production schedules and have a material negative impact on our financial condition, results of operation, and cash flows.

 

 

Selling, General and Administrative Expense

 

Selling, general and administrative (“SG&A”) expense of $4.8 million for the three months ended June 30, 2023 increased by $1.0 million, when compared to $3.8 million for the three months ended June 30, 2022. The increase in selling general and administrative expense was the result of the Company incurring approximately $1.4 million of one-time items related to organizational changes including severance and legal fees that impacted operational expense. Excluding these one-time items, selling general and administrative expense for the second quarter 2023 would have been $3.35 million or a 11% decrease from the prior year period.

 

Share-based compensation costs allocated to SG&A increased to $990 thousand compared to $589 thousand for the comparable prior quarter. This $401 thousand increase resulted primarily from changes in management and one-time costs associated with the management changes in April 2023.

 

Salaries and burden costs of $1.53 million for the three months ended June 30, 2023 was a decrease of $10 thousand, or a 1% decrease, due to reduced headcount and one-time recruiting expense. During three months ended June 30, 2023, as compared to same period during the prior year, we increased professional fees by $308 thousand, and increased consulting and contract services fees by $182 thousand. We expect expenditures for SG&A expense in 2023 to remain in line with 2022 despite expected revenue growth.

 

Advertising and promotion costs were $282 thousand for the three months ended June 30, 2023, or a decrease of $51 thousand as compared to $333 thousand during the three months ended June 30, 2022. The changes in advertising costs were related to reductions in consultants and other cost containment efforts. However, the company expects advertising costs will increase in the future due to increased investment in strategic targeting and marketing campaigns as well as building brand awareness.

 

Research and Development Expense

 

Research and development expense decreased by $474 thousand for the three months ended June 30, 2023 when compared to the three months ended June 30, 2022. We incurred a $92 thousand period over period increase in share-based compensation expense allocated to research and development expense as a result of personnel changes made in April 2023. Outside consulting costs decreased by $145 thousand and prototype related costs decreased by $155 thousand primarily due to reduced costs related to finalizing the BolaWrap 150 product and continued cost containment efforts.

 

Operating Loss

 

Loss from operations of $5.1 million during the three months ended June 30, 2023 was an increase of $0.3 million compared to loss from operations of $4.8 million during the three months ended June 30, 2022, reflecting increased margin and the focus on reducing operating costs. The increase in operating expense was the result of the Company incurring approximately $1.4 million of one-time items related to organizational changes including severance and legal fees that impacted operational expense. Excluding these one-time items, operational expense for the second quarter 2023 would have been $4.35 million or a 17% decrease from the prior year period.

 

Six Months Ended June 30, 2023 Compared to Six Months Ended June 30, 2022

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Six Months Ended

June 30,

   

Change

 
   

2023

   

2022

   

$

   

%

 

Revenue:

                               

Product sales

  $ 1,650     $ 2,431     $ (781

)

    (32

)%

Other revenue

    263       333       (70

)

    (21

)%

Total revenue

    1,913       2,764       (851

)

    (31

)%

Cost of revenue

    893       1,640       (747

)

    (46

)%

Gross profit

    1,020       1,124       (104

)

    (9

)%

                                 

Operating expense:

                               

Selling, general and administrative

    8,286       8,370       (84

)

    (1

)%

Research and development

    2,073       2,971       (898

)

    (30

)%

Total operating expense

    10,359       11,341       (982

)

    (9

)%

Loss from operations

  $ (9,339

)

  $ (10,217

)

  $ 878       (9

)%

 

 

Revenue

 

We reported net revenue of $1.9 million for the six months ended June 30, 2023, as compared to $2.8 million for the six months ended June 30, 2022, a 31% decrease over the prior year. International revenue decreased from $479 thousand for the six months ended June 30, 2022 to $35 thousand for the six months ended June 30, 2023. We believe that our sales during the six months ended June 30, 2023 were impacted by the timing of new orders and associated budgeting from our customers. We also incurred discounts of $64 thousand during the six months ended June 30, 2023, as a result of promotional programs designed to encourage customers to upgrade to the BolaWrap 150. Gross sales were $1.98 million for the six months ended June 30, 2023, before such discounts. The discounts compare to normal business discounts of $549 thousand in the comparable six-month period of the prior year. We expect a decline to minimal discounts in 2023 as we have phased out our promotional upgrade offer.

 

International revenue generally consists of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. International orders anticipated in the second quarter of 2022 were delayed significantly due to the changeover from the BolaWrap 100 but those orders for BolaWrap 150 are anticipated in future quarters. We believe that revenue during the fiscal year 2023 will increase overall compared to the revenue recorded during 2022 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given. We believe based on pipeline that these larger international deals are more likely to book and ship in the latter half of 2023.

 

We incurred product promotional costs of $95 thousand during the six months ended June 30, 2023, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. We are responding to increased demand for training as a result of expanded product and brand awareness and increased successful field use by agencies but due to awareness expect reductions in product promotional costs from the prior year.

 

We had $340 thousand of deferred revenue at June 30, 2023, of which $217 thousand related to VR, $17 thousand was related to training and $106 thousand related to BolaWrap extended warranties and services. As we potentially secure increased bookings for Wrap Reality, as well as BolaWrap extended warranties, we expect our deferred revenue to grow in future quarters. 

 

At June 30, 2023, we had backlog of $25 thousand expected to be delivered in the third quarter of 2023. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instance’s cancellation in the normal course of business. 

 

Gross Profit

 

Our gross profit for the six months ended June 30, 2023 was $1.02 million, or a gross margin of 53%. Our cost of revenue for the six months ended June 30, 2022 was $1.12 thousand resulting in a gross margin of 41%. The decrease in gross profit represented an 9% decrease over prior year as a result of decreased sales.

 

As our revenue history is limited, historical margins may not accurately reflect future margins. However, we expect higher margins with the production of the BolaWrap 150 compared to previous production due to design changes and improved pricing. Our margins are also subject to variations based on the sales channels and product mix through which our products are sold. At present, our cassettes have lower margins than BolaWrap devices. As we scale cassette production, we will look to reduce our costs and drive higher cassette margins. Cassettes were a total of 18% of our overall revenue in the six months ended June 30, 2023, and will continue to grow as a recurring revenue base as more BolaWrap devices are in the field and the usage of BolaWrap increases due to the need of officers to de-escalate earlier to prevent injuries and use of higher levels of force.

 

 

We regularly introduce updates and revisions to our products, which may include changes to raw materials and components, and can impact our product costs. Given our limited experience with warranty costs, our estimated future warranty expense may affect our gross margins.

 

Our global supply chain has experienced notable component shortages, extended lead times, cost fluctuations, and logistical constraints, all of which have affected our product costs. Although we anticipate these supply chain obstacles to ease in 2023, we acknowledge that future supplier shortages, quality problems, and logistics delays could impact our production schedules and have a material negative impact on our financial condition, results of operation, and cash flows.

 

Selling, General and Administrative Expense

 

Selling, general and administrative (SG&A”) expense of $8.3 million for the six months ended June 30, 2023 decreased, by $0.1 million, when compared to $8.4 million for the six months ended June 30, 2022, due to cost containment efforts.

 

Share-based compensation costs allocated to SG&A increased to $1.6 million compared to $1.5 million for the comparable prior-year period. This $0.1 million increase resulted primarily due to changes in management, one-time costs in the prior year period, and changes in the stock price.

 

Salaries and burden costs of $3.0 million for the six months ended June 30, 2023 was a decrease of $132 thousand, or a 4% decrease, due to reduced headcount and one-time recruiting expense. During six months ended June 30, 2023, as compared to same period during the prior year, we increased professional fees by $160 thousand, and increased consulting and contract services fees by $30 thousand. We expect expenditures for SG&A expense in 2023 to remain in line with 2022 despite expected revenue growth.

 

Advertising and promotion costs were $445 thousand for the six months ended June 30, 2023, or a decrease of $216 thousand as compared to $661 thousand during the six months ended June 30, 2022. The changes in advertising costs were related to reductions in consultants and other cost containment efforts.

 

Research and Development Expense

 

Research and development expense decreased by $898 thousand for the six months ended June 30, 2023 when compared to the six months ended June 30, 2022. We incurred a $21 thousand period over period increase in share-based compensation expense allocated to research and development expense as a result of personnel changes made in April 2023. Outside consulting costs decreased by $252 thousand and prototype related costs decreased by $323 thousand for the six months ended June 30, 2023, primarily due to reduced costs related to finalizing the BolaWrap 150 product.

 

Operating Loss

 

Loss from operations of $9.3 million during the six months ended June 30, 2023 was a reduction of $878 thousand compared to loss from operations of $10.2 million during the six months ended June 30, 2022, reflecting increased margin and the focus on reducing operating costs.

 

Liquidity and Capital Resources

 

Overview

 

Our primary source of liquidity to date has been funding from our stockholders from the sale of equity securities and the exercise of derivative securities, consisting of options and warrants. We expect our primary source of future liquidity will be from the sale of products, exercise of stock options and warrants and from future equity or debt financings.

 

We have experienced net losses and negative cash flows from operations since our inception. As of June 30, 2023, we had cash and cash equivalents of $11.7 million, short-term investments of $6.5 million, positive working capital of $16.6 million and had sustained cumulative losses attributable to stockholders of $76.4 million. Our working capital at June 30, 2023 was positively affected by an increase in inventories of approximately $2.5 million, which consisted of increases of inventory of the BolaWrap 150 in anticipation of future orders, and the receipt of $7.4 million from the Offering on June 29, 2023 that formally closed on July 5, 2023.  The Offering was consummated following an analysis of our future capital needs, resulting in the issuance of Series A Convertible Preferred Stock and Warrants.  The Offering generated gross proceeds to the Company of approximately $10 million.  As a result, we had $18.2 million in cash and cash equivalents and short-term investments as of June 30, 2023. We therefore believe we have sufficient capital to fund our operations for the next twelve months. However, liquidity constraints and access to capital markets could still negatively affect our liquidity and require changes to our investment strategy.

 

 

Capital Requirements

 

Our future liquidity requirements or future capital needs will depend on, among other things, capital required to introduce new products and the operational staffing and support requirements, as well as the timing and amount of future revenue and product costs. We anticipate that demands for operating and working capital may grow depending on decisions on staffing, development, production, marketing, training and other functions and based on other factors outside of our control, including the timing of receipt of revenue.

 

Our future capital requirements, cash flows and results of operations could be affected by, and will depend on, many factors, some of which are currently unknown to us, including, among other things:

 

 

Any future outbreaks pandemics or contagious diseases or fear of such outbreaks;

   

 

 

Decisions regarding staffing, development, production, marketing and other functions;

   

 

 

The timing and extent of market acceptance of our products;

   

 

 

Costs, timing and outcome of planned production and required customer and regulatory compliance of our products;

   

 

 

Costs of preparing, filing and prosecuting our patent applications and defending any future intellectual property-related claims;

   

 

 

Costs and timing of additional product development;

   

 

 

Costs, timing and outcome of any future warranty claims or litigation against us associated with any of our products;

   

 

 

Ability to collect accounts receivable; and

   

 

 

Timing and costs associated with any new financing.

 

Principal factors that could affect our ability to obtain cash from external sources including from exercise of outstanding warrants and options include:

 

 

Volatility in the capital markets; and

   

 

 

Market price and trading volume of our Common Stock.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

 

Cash Flow

 

Operating Activities

 

During the six months ended June 30, 2023, net cash used in operating activities was $776 thousand. The net loss of $9.04 million was decreased by non-cash expense of $2.26 million consisting primarily of share-based compensation expense of $1.85 million. Other major component changes using operating cash included an increase of $2.55 million in inventories and a net increase in accounts payable and accrued liabilities of $7.66 million. A decrease in accounts receivable of $884 million reduced the cash used in operating activities.

 

During the six months ended June 30, 2022, net cash used in operating activities was $6.2 million. The net loss of $10.2 million was decreased by non-cash expense of $2.2 million consisting primarily of share-based compensation expense of $1.76 million. Other major component changes using operating cash included an increase of $467 thousand in inventories and a net reduction in accounts payable and accrued liabilities of $311 thousand. A decrease in accounts receivable of $2.4 million reduced the cash used in operating activities.

 

Investing Activities

 

During the six months ended June 30, 2023, we used $2.65 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $10 million. During the six months ended June 30, 2023, we used $66 thousand of cash for the purchase of property and equipment, and invested $176 thousand in patents.

 

During the six months ended June 30, 2022, we used $14.9 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $20 million. During the six months ended June 30, 2022, we used $168 thousand of cash for the purchase of property and equipment and invested $102 thousand in patents.

 

Financing Activities

 

During the six months ended June 30, 2023 and 2022, we received $0 and $75 thousand, respectively, in proceeds from the exercise of previously issued stock options.

 

During the six months ended June 30, 2023 and 2022, we received $7.4 million and $0 million in gross proceeds from the issuance of securities, which amount in the six months ended June 30, 2023 is reflected in cash and cash equivalents, with an offset to accrued expense, each as reflected in the Company’s Condensed Consolidated Balance Sheet at June 30, 2023.

 

Contractual Obligations and Commitments

 

Pursuant to that certain exclusive Amended and Restated Intellectual Property License Agreement dated September 30, 2016, by and between the Company and Syzygy Licensing, LLC (“Syzygy”), we are obligated to pay to Syzygy a 4% royalty fee on future product sales up to an aggregate amount of $1.0 million in royalty payments or until September 30, 2026, whichever occurs earlier.

 

Pursuant to the Professional Services and Technology Acquisition Agreement (the “Agreement”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “Service Provider”) on November 22, 2022, as amended on April 2, 2023, which Agreement, provided that the Service Provider provide to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “Technology, Services, and License”), in consideration for a cash payment of $700 made to the Service Provider upon the execution of the Agreement.

 

In January 2022 we extended our facility lease for three years through July 2025 and we are committed to aggregate lease payments on the lease of $61 thousand for six months in 2023, $126 thousand in 2024 and $75 thousand in 2025.

 

At June 30, 2023, we were committed for approximately $3.9 million for future component deliveries and contract services that are generally subject to modification or rescheduling in the normal course of business.

 

On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Intrensic, LLC, a Delaware limited liability company (“Intrensic”), and certain members of Intrensic, including Kevin Mullins, the Company’s Chief Executive Officer (collectively, “Sellers”).  Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “Membership Interests”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests: (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the closing; and (ii) 1,250,000 shares of Common Stock of the Company.  

 

Effects of Inflation

 

During the six months ended June 30, 2023 and year ended December 31, 2022, we had experienced increased costs in labor and materials due to inflation. We believe in 2023 that low unemployment and higher salaries will create higher payroll costs and increased operating expense in the business. We have seen increases in costs from multiple suppliers for materials as well as labor.

 

 

Recent Accounting Pronouncements

 

There have been no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2023, or subsequently thereto, that we believe are of potential significance to our financial statements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, as of June 30, 2023, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies, which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future period are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We may become subject to legal proceedings, as well as demands and claims that arise in the normal course of our business, including claims of alleged infringement of third-party patents and other intellectual property rights, breach of contract, employment law violations, and other matters and matters involving requests for information from us or our customers under federal or state law. Such claims, even if not meritorious, could result in the expenditure of significant financial and management resources. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At June 30, 2023, we had no provision for liability under existing litigation.

 

An unfavorable outcome on any litigation matters could require payment of substantial damages, or, in connection with any intellectual property infringement claims, could require us to pay ongoing royalty payments or could prevent us from selling certain of our products. As a result, a settlement of, or an unfavorable outcome on, any of the matters referenced above or other litigation matters, or legal proceedings could have a material adverse effect on our business, operating results, financial condition and cash flows.

 

 

Item 1A. Risk Factors

 

Management is not aware of any material changes to the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2022.  In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent reports filed pursuant to the Exchange Act which could materially and adversely affect the Companys business, financial condition, results of operations, and stock price. The risks described in the Annual Report on Form 10-K and subsequent reports filed pursuant to the Exchange Act are not the only risks facing the Company. Additional risks and uncertainties not presently known to management, or that management presently believes not to be material, may also result in material and adverse effects on our business, financial condition, and results of operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

No unregistered securities were issued during the three months ended June 30, 2023, that were not previously reported.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

Exhibit 10.1

Separation Agreement between the Company and Mr. Kennedy, incorporated by reference from Exhibit 10.1 to the Current Report on Form 8-K, filed on April 19, 2023.

Exhibit 31.1

Certification of Kevin Mullins, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 31.2

Certification of Chris DeAlmeida, Principal Accounting Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Kevin Mullins, Principal Executive Officer, and Chris DeAlmeida, Principal Accounting Officer.*

 

 

Extensible Business Reporting Language (XBRL) Exhibits*

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101)

 

* Filed concurrently herewith

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

WRAP TECHNOLOGIES, INC.

   
 

By:

/s/ CHRIS DEALMEIDA

August 9, 2023

 
   

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

-29-
EX-31.1 2 ex_548043.htm EXHIBIT 31.1 ex_548043.htm

Exhibit 31.1

 

CERTIFICATION

 

I, Kevin Mullins, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 9, 2023

 

/s/ KEVIN MULLINS                           

Kevin Mullins

Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_548044.htm EXHIBIT 31.2 ex_548044.htm

Exhibit 31.2

 

CERTIFICATION

 

I, Chris DeAlmeida, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: August 9, 2023

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 
EX-32.1 4 ex_548045.htm EXHIBIT 32.1 ex_548045.htm

Exhibit 32.1

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Each of the undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his or her capacity as an officer of Wrap Technologies, Inc. (the “Company”), that, to his or her knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended June 30, 2023, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: August 9, 2023

 

/s/ KEVIN MULLINS                  

Kevin Mullins

Chief Executive Officer

(Principal Executive Officer)

 

Date: August 9, 2023

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 
EX-101.SCH 5 wrap-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Revenue and Product Costs link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Financial Instruments link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Inventories link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Property and Equipment, Net link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Intangible Assets, Net link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Defined Contribution Plan link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Major Customers and Related Information link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 2 - Revenue and Product Costs (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 3 - Financial Instruments (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 4 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 5 - Property and Equipment, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 6 - Intangible Assets, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 9 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 13 - Major Customers and Related Information (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 2 - Revenue and Product Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Revenue and Product Costs - Contract Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Financial Instruments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Inventories - Summary of Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 6 - Intangible Assets, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 6 - Intangible Assets, Net - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 6 - Intangible Assets, Net - Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Summary of Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) link:calculationLink